Propulsid Revised Labeling Reserves Drug For Second-Line Use In GERD

Janssen's Propulsid (cisapride) should be reserved for second-line use, revised labeling recommends following additional reports of cardiac events and deaths associated with the drug for nocturnal heartburn caused by gastroesophageal reflux disease.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet